To require training for prescribers of controlled substances, and for other purposes.
USA115th CongressHR-5581| House
| Updated: 5/22/2018
Susan W. Brooks
Republican Representative
Indiana
Cosponsors (1)
Crime and Federal Government Surveillance Subcommittee, Judiciary Committee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Abuse Deterrent and Prescriber Training Act of 2018 or the ADAPT Act of 2018 This bill amends the Controlled Substances Act to prohibit the Drug Enforcement Administration from registering, or renewing the registration of, a practitioner who is licensed to prescribe opioids in schedule II, III, IV, or V unless the practitioner completes a training program that includes information on opioids. The Government Accountability Office must report to Congress on the effects of the amendments made by this bill, including whether there has been a reduction in opioids prescribed and in opioid-related overdoses and death.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Crime and Law Enforcement
CancerCongressional oversightDrug, alcohol, tobacco useDrug trafficking and controlled substancesGovernment studies and investigationsHealth personnelLicensing and registrationsLong-term, rehabilitative, and terminal careMedical educationPrescription drugs
To require training for prescribers of controlled substances, and for other purposes.
USA115th CongressHR-5581| House
| Updated: 5/22/2018
Abuse Deterrent and Prescriber Training Act of 2018 or the ADAPT Act of 2018 This bill amends the Controlled Substances Act to prohibit the Drug Enforcement Administration from registering, or renewing the registration of, a practitioner who is licensed to prescribe opioids in schedule II, III, IV, or V unless the practitioner completes a training program that includes information on opioids. The Government Accountability Office must report to Congress on the effects of the amendments made by this bill, including whether there has been a reduction in opioids prescribed and in opioid-related overdoses and death.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Susan W. Brooks
Republican Representative
Indiana
Cosponsors (1)
Crime and Federal Government Surveillance Subcommittee, Judiciary Committee, Energy and Commerce Committee
Crime and Law Enforcement
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
CancerCongressional oversightDrug, alcohol, tobacco useDrug trafficking and controlled substancesGovernment studies and investigationsHealth personnelLicensing and registrationsLong-term, rehabilitative, and terminal careMedical educationPrescription drugs